Short Course 1: eCOA 101: The What, Why, and How of eCOA to Reduce Barriers to Adoption in Clinical Studies
Paul O'Donohoe, MS, MSc
- Scientific Lead, eCOA and Mobile Health
- Medidata Solutions, United States
Paul O’Donohoe is Scientific Lead, eCOA and Mobile Health at Medidata Solutions, a clinical software platform provider. He is responsible for developing the company's scientific expertise for electronic clinical outcome assessments and mobile health in clinical trials, and supports internal teams and Sponsors around the implementation of industry and regulatory best practices in studies using eCOA. He is passionate about developing the field of eCOA and mobile health through research and active involvement in industry consortia, and is currently the Industry Vice-Director of the C-Path ePRO Consortium.
- Senior Manager, Patient-Centered Outcomes Research
- Genentech, A Member of the Roche Group, United States
Ms Zarzar focuses on improving the execution of COA strategies to generate patient-relevant evidence. Her past experience includes 3 years supporting the development and delivery of PCOR strategies at Roche, and six years at TransPerfect leading the design and oversight of linguistic validation programs for a variety of sponsors. Past publication topics include linguistic validation methodology, development of measures in a global context, and improving translation and eCOA delivery in global trials. Katie is passionate about designing systems that enable development and implementation of robust patient-centered outcomes strategies, as well as exploring new technologies and methods for capturing the patient experience.